跳至主要内容
临床试验/NCT03909048
NCT03909048已完成不适用

Chronic Low Back Pain Graded - Exposure Psychoeducation Intervention

University of Alabama at Birmingham2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Daily Pain Monitoring: 10 point scale

研究概览

简要总结

This study will examine the effectiveness of one of two psychoeducation treatments on chronic low back pain.

详细描述

This study will examine the effectiveness of one of two psychoeducation treatments on chronic low back pain. Participants will be randomized to one of these two treatments.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

Participant, statistician, and outcomes assessor are blinded.

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • report having low back pain for more than three months and at least half the days in the past 6 months
  • be 18-65 years of age,
  • have scores higher than 37 on the Tampa Scale of Kinesiophobia,

排除标准

  • medical conditions other than back pain that significantly impair movement (e.g., arthritis)
  • confirmed/suspected pregnancy
  • pending litigation related to an episode of low back pain
  • significant impairment in vision

研究组 & 干预措施

Interactive Psycho-education

Experimental

Interactive psycho-education using interactive dashboard.

干预措施: Interactive - Psychoeducation (Behavioral)

Psycho-education

Placebo Comparator

Non-interactive psycho-education not using interactive dashboard.

干预措施: Non-interactive Psychoeducation (Behavioral)

结局指标

主要结局

Daily Pain Monitoring: 10 point scale

时间窗: Baseline - Final assessment (average 1 week post treatment)

Daily pain monitoring defined as daily pain intensity and daily pain interference monitoring is two questions asked daily on a 10 point scale assessing daily pain and how much pain had interfered with day to day activities. Pain: Over the past 24 hours, how would you rate your back pain on average? (0=No Pain; 10=Worst Imaginable Pain) Interference: Over the past 24 hours, how much did pain interfere with your day-to-day activities? (0=No Interference; 10 = A great deal of interference)"

Pain Intensity as assessed by Numeric Rating Scale

时间窗: Baseline - Final assessment (average 1 week post treatment)

The Numeric Rating Scale (NRS) measures pain intensity measured via 0-10 numeric rating scale. 0 = No Pain - 10 = Worst Possible Pain Range of scores: 0-10

Present Pain Intensity

时间窗: Baseline - Final assessment (average 1 week post treatment)

Present Pain Intensity (PPI) assesses present pain intensity on a scale of 0 (no pain) to 5 (excruciating)

Present Pain Rating

时间窗: Baseline - Final assessment (average 1 week post treatment)

Pain Rating Index (PRI) is assessed by 15 questions assessing pain in the sensory and affective dimensions. Items rate from 0 (none) to 3 (severe) on degree to which the words apply to pain. Score Range: 0-45

Pain Chronicity assessed by the Graded Chronic Pain Scale

时间窗: Baseline - Final assessment (average 1 week post treatment)

Pain Chronicity is assessed by the Graded Chronic Pain Scale (GCPS). The GCPS is 7 questions with 3 sub-scales (Characteristic pain intensity, disability score, and disability points). Scoring: Characteristic Pain Intensity: is a 0 to 100 score derived from Questions 1 through 3: Mean (Pain Right Now, Worst Pain, Average Pain) X 10. Disability Score: is 0 to 100 score derived from Questions 4 through 6: Mean (Daily Activities, Social Activities, Work Activities) X 10 Disability Points: Add the indicated points for Disability Days (Question 7) and for Disability Score (0-6). Items rate from 0 to 10 with 0 referencing no pain/interference/change and 10 referencing pain as bad as could be/unable to carry out any activities/extreme change.

次要结局

  • Back Disability as assessed by the Roland Morris Disability Questionnaire(Baseline - Final assessment (average 1 week post treatment))
  • Daily intervention feedback questions(Baseline - Final assessment (average 1 week post treatment))
  • Depressive symptoms as assessed by the Center for Epidemiologic Studies Depression Scale(Baseline - Final assessment (average 1 week post treatment))
  • Pain Catastrophizing as assessed by the Pain Catastrophizing Scale(Baseline - Final assessment (average 1 week post treatment))
  • Video Game Preferences as assessed by the BrainHex(Final assessment (average 1 week post treatment))
  • Mood and Affect as assessed by the Positive and Negative Affect Scale(Baseline - Final assessment (average 1 week post treatment))
  • Patient Treatment Evaluation as assessed by the Usefulness, Satisfaction, and Ease of Use Questionnaire(Final assessment (average 1 week post treatment))
  • Immersive Tendencies(Baseline only)
  • Absorption Tendencies(Baseline Only)
  • Video Game History(Baseline Only)
  • Patient Treatment Evaluation as assessed by the Modified Treatment Evaluation Inventory(Final assessment (average 1 week post treatment))
  • Pain-related fear of movement as assessed by the Tampa Scale Kinesiophobia(Baseline - Final assessment (average 1 week post treatment))
  • Patient Treatment Evaluation as assessed by the Patient Global Impression of Change Scale(Final assessment (average 1 week post treatment))
  • Patient Treatment Evaluation as assessed by Semi-structured Qualitative interviewing(Final assessment (average 1 week post treatment))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zina Trost

Assistant Professor

University of Alabama at Birmingham

研究点 (2)

Loading locations...

相似试验